Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009607 |
---|---|
Receipt number | R000011266 |
Scientific Title | The double-blind, randomised controlled phase II study of the adjuvant therapy using alpha-galactosylceramide pulsed antigen presenting cells for patients with head and neck mucosal melanoma followed by standard therapy. |
Date of disclosure of the study information | 2013/04/01 |
Last modified on | 2020/08/15 14:17:19 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/12/21 16:52:26 | ||
2 | Update | 2013/06/27 07:55:18 | Recruitment status |
|
3 | Update | 2020/08/15 14:17:19 | Recruitment status Date of IRB Last follow-up date |